Latest Breaking News On - மேற்கு வேல்ஸ் ஜநரல் மருத்துவமனை - Page 1 : comparemela.com
Attacking Gates, attacking vaccines: How conflict, religion and conspiracy theories drive COVID-19 misinformation in Nigeria
guardian.ng - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from guardian.ng Daily Mail and Mail on Sunday newspapers.
Easing of Covid rules will not be delayed indefinitely, Drakeford says
wharfedaleobserver.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wharfedaleobserver.co.uk Daily Mail and Mail on Sunday newspapers.
Wales postpones changes to Covid restrictions amid Delta variant spread
pressandjournal.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pressandjournal.co.uk Daily Mail and Mail on Sunday newspapers.
People who receive a Moderna Covid-19 jab will be asked to wait for 15 minutes of observation after they receive their vaccine.
Details about the vaccine have been published by the Government as it prepares for the vaccine to be rolled out across England.
The Department of Health and Social Care reiterated that the jab will be rolled out from mid-April after first doses have already been delivered in Wales and Scotland.
A 24-year-old carer from Wales was the first Briton to receive the jab last week.
Elle Taylor, from Ammanford, got the jab at the West Wales General Hospital in Carmarthen on April 7.
The Moderna coronavirus vaccine is set to be rolled out in England from Tuesday.
It comes after the first doses were delivered in Wales and Scotland last week and follows the rollout of the Pfizer and AstraZeneca vaccines, which began in December and January respectively.
Adults in their late 40s in England are set to be offered a first dose of a coronavirus vaccine this week.
Here’s what we know about the Moderna vaccine.
– How effective is it against coronavirus?
The phase three results suggested vaccine efficacy against the disease was 94.1%, and vaccine efficacy against severe Covid-19 was 100%.
More than 30,000 people in the US took part in the trial, from a wide range of age groups and ethnic backgrounds.